IMMUNOPATOLOGIA
National Institutes of Health
Bethesda, Estados UnidosNational Institutes of Health-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2020
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2014
-
Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation
Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 5, pp. 1190-1193.e1
2013
-
Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells
Journal of Immunology, Vol. 191, Núm. 4, pp. 1883-1894
-
Mouse IgM Fc receptor, FCMR, promotes b cell development and modulates antigen-driven immune responses
Journal of Immunology, Vol. 190, Núm. 3, pp. 987-996
2012
-
Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells
Journal of Immunology, Vol. 189, Núm. 2, pp. 587-597
2008
-
Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor
Traffic, Vol. 9, Núm. 6, pp. 1019-1034
2004
-
Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system™
Journal of Immunological Methods, Vol. 284, Núm. 1-2, pp. 133-140
1998
-
HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
Journal of Biomedical Science, Vol. 5, Núm. 5, pp. 321-331